共 50 条
- [1] RILOMET-1: An international phase III multicenter, randomized, double-blind, placebo-controlled trial of rilotumumab plus epirubicin, cisplatin, and capecitabine (ECX) as first-line therapy in patients with advanced MET-positive gastric or gastroesophageal junction (G/GEJ) adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Cunningham, David论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandAl-Batran, Salah-Eddin论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandDavidenko, Irina论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandIlson, David H.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandMurad, Andre M.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandTebbutt, Niall C.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandJiang, Yizhou论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandLou, Elwyn论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, EnglandDubey, Santa论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp NHS Fdn Trust, London, England
- [2] Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 studyJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Cunningham, David论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandTebbutt, Niall C.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandDavidenko, Irina论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandMurad, Andre M.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandAl-Batran, Salah-Eddin论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandIlson, David H.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandTjulandin, Sergei论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandGotovkin, Evgeny论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandKaraszewska, Boguslawa论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandBondarenko, Igor论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandTejani, Mohamedtaki Abdulaziz论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandUdrea, Anghel Adrian论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandTehfe, Mustapha Ali论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandBaker, Nigel论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandOliner, Kelly Smith论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandZhang, Yilong论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandHoang, Tien论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandSidhu, Roger论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, EnglandCatenacci, Daniel Virgil Thomas论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Sutton, Surrey, England
- [3] A phase 3, multicenter, randomized, double-blind, placebo-controlled study of rilotumumab in combination with cisplatin and capecitabine (CX) as first-line therapy for Asian patients (pts) with advanced MET-positive gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The RILOMET-2 trialJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)Doi, Toshihiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanKang, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanMuro, Kei论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanJiang, Yizhou论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanJain, Rajul K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanLizambri, Richard论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
- [4] AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC)JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)Kang, Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaOhtsu, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaRha, S. Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaSawaki, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaPark, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaLim, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaWu, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaLanger, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South KoreaShah, M. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
- [5] First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trialCLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (04): : 495 - 502Quintero Aldana, G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainSalgado, M.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ Ourense, Dept Med Oncol, Orense, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainCandamio, S.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ Santiago de Compostela, Dept Med Oncol, Santiago De Compostela, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainMendez, J. C.论文数: 0 引用数: 0 h-index: 0机构: Ctr Oncol Galicia, Dept Med Oncol, La Coruna, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainJorge, M.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Xeral Cies, Dept Med Oncol, Vigo, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainReboredo, M.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ A Coruna, Dept Med Oncol, La Coruna, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainVazquez Tunas, L.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Pontevedra, Dept Med Oncol, Pontevedra, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainRomero, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp POVISA, Dept Med Oncol, Vigo, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainCovela, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainFernandez Montes, A.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ Ourense, Dept Med Oncol, Orense, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainCarmona, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainVidal Insua, Y.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ Santiago de Compostela, Dept Med Oncol, Santiago De Compostela, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, SpainLopez, R.论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ Santiago de Compostela, Dept Med Oncol, Santiago De Compostela, Spain CIBERONC, Madrid, Spain Hosp Univ Lucus Augusti, Dept Med Oncol, Calle Doctor Ulises Romero 1, Lugo 27003, Spain
- [6] First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trialClinical and Translational Oncology, 2020, 22 : 495 - 502G. Quintero Aldana论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyM. Salgado论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyS. Candamio论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyJ. C. Méndez论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyM. Jorge论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyM. Reboredo论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyL. Vázquez Tuñas论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyC. Romero论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyM. Covela论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyA. Fernández Montes论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyM. Carmona论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyY. Vidal Insua论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical OncologyR. López论文数: 0 引用数: 0 h-index: 0机构: Hospital Universitario Lucus Augusti,Department of Medical Oncology
- [7] Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialBMJ-BRITISH MEDICAL JOURNAL, 2024, 385Qiu, Miao-Zhen论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaOh, Do-Youn论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Seoul Natl Univ Hosp, Seoul Natl Univ Grad Sch, Canc Res Inst,Coll Med,Innovat Med Sci, Seoul, South Korea Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaKato, Ken论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Dept Head & Neck Esophageal Med Oncol & Gastrointe, Tokyo, Japan Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaArkenau, Tobias论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res, London, England Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaCorrea, Marcia Cruz论文数: 0 引用数: 0 h-index: 0机构: Univ Puerto Rico, San Juan, PR USA Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaZimina, Anastasia, V论文数: 0 引用数: 0 h-index: 0机构: BHI Omsk Reg Clin Oncol Dispensary, Omsk, Russia Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaBai, Yuxian论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ Canc Hosp, Harbin, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaShi, Jianhua论文数: 0 引用数: 0 h-index: 0机构: Linyi Canc Hosp, Linyi, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaLee, Keun-Wook论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Seoul Natl Univ Coll Med, Dept Pathol, Seongnam, South Korea Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaWang, Jufeng论文数: 0 引用数: 0 h-index: 0机构: Henan Canc Hosp, Zhengzhou, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaPoddubskaya, Elena论文数: 0 引用数: 0 h-index: 0机构: Oncol Clin Vitamed, Moscow, Russia Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaPan, Hongming论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Oncol Dept, Hangzhou, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaRha, Sun Young论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Yonsei Canc Ctr, Seoul, South Korea Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaZhang, Ruixing论文数: 0 引用数: 0 h-index: 0机构: Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaHirano, Hidekazu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Gastrointestinal Med Oncol, Tokyo, Japan Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaSpigel, David论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaYamaguchi, Kensei论文数: 0 引用数: 0 h-index: 0机构: Canc Inst Hosp JFCR, Gastroenterol Chemotherapy, Tokyo, Japan Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaChao, Yee论文数: 0 引用数: 0 h-index: 0机构: Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaWyrwicz, Lucjan论文数: 0 引用数: 0 h-index: 0机构: Narodowy Inst Onkol, Warsaw, Poland Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaDisel, Umut论文数: 0 引用数: 0 h-index: 0机构: Acibadem Adana Hosp, Adana, Turkiye Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaCid, Roberto Pazo论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Miguel Servet, Zaragoza, Spain Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaFornaro, Lorenzo论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Pisa, Italy Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaEvesque, Ludovic论文数: 0 引用数: 0 h-index: 0机构: Ctr Antoine Lacassagne, Nice, France Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaWang, Hongwei论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Boston, MA USA Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaXu, Yaling论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Shanghai, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaLi, Jiang论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Boston, MA USA Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaSheng, Tao论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Boston, MA USA Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaYang, Silu论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Beijing, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaLi, Liyun论文数: 0 引用数: 0 h-index: 0机构: BeiGene, Beijing, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaMoehler, Markus论文数: 0 引用数: 0 h-index: 0机构: Johannes Gutenberg Univ Clin, Gastrointestinal Oncol, Mainz, Germany Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R ChinaXu, Rui-Hua论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R China Chinese Acad Med Sci, Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr,State Key Lab Oncol South, Guangzhou, Peoples R China
- [8] Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 studyLANCET ONCOLOGY, 2018, 19 (10): : 1372 - 1384Tabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Univ Autonoma Barcelona, Ctr Invest Biomed Red Canc, Inst Oncol, Barcelona, Spain Vall dHebron Univ Hosp, Barcelona, SpainHoff, Paulo M.论文数: 0 引用数: 0 h-index: 0机构: Univ Sao Paulo, Inst Canc Sao Paulo, Fac Med, Sao Paulo, Brazil Vall dHebron Univ Hosp, Barcelona, SpainShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Dept Gastrointestinal Oncol, Beijing, Peoples R China Vall dHebron Univ Hosp, Barcelona, SpainOhtsu, Atsushi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan Vall dHebron Univ Hosp, Barcelona, SpainShah, Manish A.论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Coll, Meyer Cancerctr, Med Oncol Solid Tumor Program, New York, NY USA Vall dHebron Univ Hosp, Barcelona, SpainCheng, Karen论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA Vall dHebron Univ Hosp, Barcelona, SpainSong, Chunyan论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA Vall dHebron Univ Hosp, Barcelona, SpainWu, Haiyan论文数: 0 引用数: 0 h-index: 0机构: Roche Holding Ltd, Biostat, Biometr, Shanghai, Peoples R China Vall dHebron Univ Hosp, Barcelona, SpainEng-Wong, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA Vall dHebron Univ Hosp, Barcelona, SpainKim, Katherine论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA Vall dHebron Univ Hosp, Barcelona, SpainKong, Yoon-Koo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul 05505, South Korea Vall dHebron Univ Hosp, Barcelona, Spain
- [9] Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trialLANCET ONCOLOGY, 2014, 15 (11): : 1224 - 1235Wilke, Hansjochen论文数: 0 引用数: 0 h-index: 0机构: Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, Germany Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyMuro, Kei论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Leuven, Belgium Katholieke Univ Leuven, Leuven, Belgium Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyOh, Sang-Cheul论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Guro Hosp, Seoul, South Korea Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyBodoky, Gyoergy论文数: 0 引用数: 0 h-index: 0机构: St Laszlo Hosp, Budapest Gastrointestinal Med Oncol, Dept Oncol, Budapest, Hungary Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyShimada, Yasuhiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Tokyo, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyHironaka, Shuichi论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanySugimoto, Naotoshi论文数: 0 引用数: 0 h-index: 0机构: Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyLipatov, Oleg论文数: 0 引用数: 0 h-index: 0机构: Republican Clin Oncol Dispensary, Ufa, Russia Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyKim, Tae-You论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Canc Hosp, Seoul, South Korea Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyCunningham, David论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, London SW3 6JJ, England Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, Germany论文数: 引用数: h-index:机构:Komatsu, Yoshito论文数: 0 引用数: 0 h-index: 0机构: Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyAjani, Jaffer论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyEmig, Michael论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly Deutschland, Bad Hamburg, Germany Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyCarlesi, Roberto论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly Italia, Sesto Fiorentino, Italy Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyFerry, David论文数: 0 引用数: 0 h-index: 0机构: New Cross Hosp, Wolverhampton, England Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyChandrawansa, Kumari论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Bridgewater, NJ USA Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanySchwartz, Jonathan D.论文数: 0 引用数: 0 h-index: 0机构: Stemline Therapeut, New York, NY USA Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, GermanyOhtsu, Atsushi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Tokyo, Japan Kliniken Essen Mitte, Dept Med Oncol Haematol, D-45136 Essen, Germany
- [10] Ramucirumab plus Paclitaxel versus Placebo plus Paclitaxel in Patients with Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma (RAINBOW): A Double-Blind, Randomised Phase 3 TrialTUMORBOARD, 2015, 4 (01): : 18 - 19Leitner, H.论文数: 0 引用数: 0 h-index: 0